Patrice Coissac is SVP & Pres. ALXN Pharma Int'l at ALEXION PHARMACEUTICALS INC (ALXN). They have made 7 open-market trades across 1 company since 2010, most recently 2012-10-31.
CIK 0001341212
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 13,148 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2012-11-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2012-10-31 | 2012-11-02 | $91.16 | $7.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-08-27 | 2012-08-29 | $106.82 | $6.8M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-02-23 | 2012-02-24 | $85.03 | $7.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-11-16 | 2011-11-18 | $66.87 | $4.9M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-03-10 | 2011-03-14 | $97.47 | $4.4M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-02-17 | 2011-02-22 | $92.86 | $4.8M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-10-27 | 2010-10-28 | $67.18 | $262K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.